Boehringer, Seqster ink 3-year health data deal to accelerate research

By Nick Taylor

- Last updated on GMT

(Yevhen Lahunov/iStock via Getty Images Plus)
(Yevhen Lahunov/iStock via Getty Images Plus)

Related tags: data analytics, Data management, Boehringer ingelheim, Clinical trials, Research, Takeda

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Boehringer Ingelheim has struck a three-year deal to work with Seqster to standardize and visualize health data.

Seqster, which raised funding from groups including Takeda last year, is working to provide accelerated access to de-identified, tokenized, and real-time health data. Paul Petraro, global head of the real-world evidence (RWE) center of excellence at Boehringer, explained the appeal of the system for his company.

To truly close the real world evidence gap, we must think differently about the data that we access with full patient consent and control. Simultaneously, we must provide full transparency for patients who we engage with in all of our studies and trials. With the SeqsterOS we have a ready-to-go solution​,” said Petraro.

Ardy Arianpour, CEO and co-founder of Seqster, envisages the collaboration benefiting Boehringer teams running clinical trials by driving “speed through real-time health data collection, study design flexibility, and control, as well as high quality and high fidelity real-world data​.”

Seqster’s system, which is applicable to retrospective and prospective health data, automates health data collection for researchers to address a barrier to the scaling of studies.

The traditional manual collection of medical history data takes weeks, if not months. This is not a sustainable model when scaling to a large number of study participants​,” said the Seqster CEO.

Boehringer will also be able to use the Digital Front Door to standardize and visualize health information. The system provides researchers with access to patient-consented data first and, as a study continues, the data connection persists to allow longitudinal data flow.

For study participants, the system could streamline the consent and re-consent processes. Patients can electronically consent to join a clinical study and to collect their medical records instantaneously.

The Digital Front Door empowers the patient to have full visibility into the study they are participating in and engages them by putting their health data at the center. eConsent and re-consent help overcome the drop-off rates and other hurdles to effectively running clinical studies. Making the consent as well as the data collection processes simple for the study participant increases their likelihood of staying in the current study as well as their interest to participate in future studies​,” said Arianpour. 

Related news

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more